Private Banking
|
Professional Solutions
|
Investment Management
|
Investment Banking
|
About us
EN
Contact
Login
Van Lanschot Kempen Logo
Solutions
Sectors
Careers
Van Lanschot Kempen Logo
Login
Home
Investment Banking
Corporate Finance
Transactions
2014
Argenx September
argenx floated on Euronext Brussels with an initial market capitalisation of €132m
Proceeds of the IPO will be used to advance the clinical development of differentiated therapeutic antibody candidates
Kempen & Co acted as Joint Global Coordinator and Joint Bookrunner and placed the majority of shares with long only specialist investors